Share This Page
Drug Price Trends for NDC 69452-0133
✉ Email this page to a colleague
Average Pharmacy Cost for 69452-0133
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DOFETILIDE 500 MCG CAPSULE | 69452-0133-17 | 0.21696 | EACH | 2025-04-23 |
| DOFETILIDE 500 MCG CAPSULE | 69452-0133-17 | 0.21862 | EACH | 2025-03-19 |
| DOFETILIDE 500 MCG CAPSULE | 69452-0133-17 | 0.20957 | EACH | 2025-02-19 |
| DOFETILIDE 500 MCG CAPSULE | 69452-0133-17 | 0.19088 | EACH | 2025-01-22 |
| DOFETILIDE 500 MCG CAPSULE | 69452-0133-17 | 0.19052 | EACH | 2024-12-18 |
| DOFETILIDE 500 MCG CAPSULE | 69452-0133-17 | 0.15771 | EACH | 2024-11-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 69452-0133
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| DOFETILIDE 500MCG CAP | Golden State Medical Supply, Inc. | 69452-0133-17 | 60 | 66.02 | 1.10033 | 2023-06-16 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 69452-0133: Navigating the Pharmaceutical Landscape
The pharmaceutical industry is a complex and ever-evolving sector, with drug pricing and market dynamics playing crucial roles in shaping its future. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug identified by National Drug Code (NDC) 69452-0133, offering valuable insights for industry professionals and stakeholders.
Understanding NDC 69452-0133
Before we dive into the market analysis, it's essential to understand what NDC 69452-0133 represents. The National Drug Code is a unique, three-segment number assigned by the U.S. Food and Drug Administration (FDA) to human drugs in the United States. For NDC 69452-0133:
- 69452 is the labeler code, identifying the manufacturer or distributor
- 01 is the product code, specifying the strength, dosage form, and formulation
- 33 is the package code, indicating the package size and type
This specific NDC belongs to a drug product manufactured or distributed by Bionpharma Inc., as indicated by the labeler code[4].
Current Market Position
To accurately assess the market position of NDC 69452-0133, we need to consider various factors, including its therapeutic category, competition, and current pricing strategies.
Therapeutic Category and Indications
While the search results don't provide specific information about the therapeutic category of NDC 69452-0133, we can draw insights from similar products by the same manufacturer. For instance, NDC 69452-0146 is associated with Progesterone, a hormone used in various treatments, including hormone replacement therapy and certain reproductive health conditions[2][4].
Competitive Landscape
The competitive landscape for pharmaceuticals is increasingly complex, with factors such as generic competition, biosimilars, and innovative therapies all playing a role. For drugs in established therapeutic categories, competition can be fierce, leading to pricing pressures and the need for differentiation strategies.
"Mid-single-digit percent annual price erosion is expected in the generic drug industry, along with modest revenue growth. This is an improvement from recent trends but is subject to risks such as price-fixing litigation and increased FDA inspections of foreign manufacturing facilities."[3]
Pricing Mechanisms and Current Trends
Understanding the pricing mechanisms is crucial for projecting future prices for NDC 69452-0133. Several key factors influence pharmaceutical pricing:
Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)
For drugs under the Medicaid Drug Rebate Program, the AMP and URA are critical in determining the ceiling price. The ceiling price is calculated as AMP minus URA, adjusted for package and case pack sizes[2].
Maximum Allowable Cost (MAC) Lists
Pharmacy benefit managers use MAC lists to determine reimbursement rates for drugs. These lists must be updated regularly to ensure fair reimbursement and competitive pricing[2].
Recent Pricing Trends
Recent data from the Department of Health and Human Services provides insights into overall drug pricing trends:
"From January 1, 2022 to January 1, 2023, the average price increase (among NDCs with a price increase) was $589.68 per drug. This is nearly 3.5 times the average price change between 2021 and 2022 ($171.50), and several times larger than any other year during the observation period."[5]
This significant increase underscores the volatility in drug pricing and the potential for substantial year-over-year changes.
Factors Influencing Future Pricing
Several key factors will likely influence the future pricing of NDC 69452-0133:
Legislative and Regulatory Changes
The pharmaceutical industry is heavily regulated, and changes in legislation can significantly impact drug pricing. For instance, the implementation of the Inflation Reduction Act (IRA) and its provisions for Medicare drug price negotiations could have far-reaching effects on pricing strategies across the industry[8].
Market Demand and Clinical Adoption
The demand for a drug and its uptake in clinical practice play crucial roles in pricing. If NDC 69452-0133 is part of a treatment algorithm that is increasingly adopted, it may experience stable or even increasing prices due to high demand[3].
Generic Competition and Patent Expiry
The entry of generic competitors can significantly impact the pricing of branded drugs. If NDC 69452-0133 is a branded product nearing patent expiry, it may face pricing pressures in anticipation of generic competition[4].
Price Projections for NDC 69452-0133
While specific price projections for NDC 69452-0133 are not available in the search results, we can make informed estimates based on industry trends and comparable products.
Short-term Projections (1-2 years)
Given the recent trend of significant price increases across the pharmaceutical industry, it's reasonable to expect that NDC 69452-0133 may see price adjustments in the short term. However, the magnitude of these changes will depend on factors such as:
- The drug's current market position
- Competition within its therapeutic category
- Any upcoming patent expirations or generic entries
Medium-term Projections (3-5 years)
In the medium term, pricing for NDC 69452-0133 will likely be influenced by broader industry trends, including:
- The implementation of Medicare drug price negotiations under the IRA
- Ongoing efforts to address drug pricing at the federal and state levels
- Potential shifts in healthcare delivery and reimbursement models
Long-term Projections (5+ years)
Long-term pricing projections are inherently uncertain but will be shaped by factors such as:
- Technological advancements in drug development and manufacturing
- Changes in global pharmaceutical supply chains
- Evolving patient demographics and healthcare needs
Strategies for Stakeholders
Given the complex and dynamic nature of pharmaceutical pricing, stakeholders should consider the following strategies:
For Manufacturers
- Invest in value demonstration through real-world evidence and outcomes-based contracts
- Explore innovative pricing models that align with value-based care initiatives
- Develop robust market access strategies that account for evolving payer landscapes
For Payers and PBMs
- Implement sophisticated data analytics to inform formulary decisions and contract negotiations
- Explore outcomes-based agreements that tie reimbursement to clinical effectiveness
- Collaborate with manufacturers on innovative pricing models that balance access and affordability
For Healthcare Providers
- Stay informed about pricing trends and their potential impact on patient access and adherence
- Advocate for transparent pricing and value-based care models
- Engage in shared decision-making with patients, considering both clinical outcomes and financial implications
The Role of Data in Price Projections
Accurate price projections rely heavily on robust data analysis. Stakeholders should leverage:
- Historical pricing data to identify trends and patterns
- Market intelligence on competitor pricing strategies
- Clinical trial data and real-world evidence to support value propositions
"To project future prices, historical pricing data for the drug must be analyzed. This includes reviewing the ceiling price charts, AMP, and URA over time to identify trends and any corrections or updates to the pricing."[2]
Navigating Uncertainty in Pharmaceutical Pricing
The pharmaceutical pricing landscape is characterized by uncertainty, driven by factors such as:
- Ongoing policy debates around drug pricing reform
- The potential impact of emerging technologies on drug development and manufacturing costs
- Shifts in global healthcare priorities, as highlighted by recent public health crises
Stakeholders must remain agile and prepared to adapt their strategies in response to these evolving dynamics.
The Future of Drug Pricing: Trends to Watch
As we look to the future of drug pricing, several key trends are likely to shape the landscape:
Increased Transparency
There is growing pressure for greater transparency in drug pricing, with initiatives aimed at providing consumers and healthcare providers with more information about the true costs of medications.
Value-Based Pricing Models
The shift towards value-based healthcare is likely to accelerate, with pricing models increasingly tied to clinical outcomes and real-world effectiveness.
Personalized Medicine and Pricing
As personalized medicine advances, we may see more nuanced pricing strategies that reflect the targeted nature of these therapies and their potential for improved outcomes in specific patient populations.
Key Takeaways
- The pricing of NDC 69452-0133 is influenced by a complex interplay of factors, including regulatory changes, market dynamics, and competitive pressures.
- Recent trends indicate significant price increases across the pharmaceutical industry, with an average increase of $589.68 per drug from 2022 to 2023.
- Future pricing projections must account for legislative changes, such as the implementation of Medicare drug price negotiations under the Inflation Reduction Act.
- Stakeholders should adopt data-driven strategies and remain agile in response to the evolving pharmaceutical pricing landscape.
- The future of drug pricing is likely to be characterized by increased transparency, value-based models, and personalized approaches.
FAQs
-
Q: How often are drug prices typically adjusted? A: Drug prices can be adjusted at any time, but many manufacturers make annual adjustments. However, the frequency and magnitude of price changes can vary widely depending on factors such as market conditions, competition, and regulatory environment.
-
Q: What impact does generic competition have on drug pricing? A: Generic competition typically leads to significant price reductions for branded drugs. Once generics enter the market, prices for the original branded drug can drop by 20-80% or more, depending on the number of generic competitors.
-
Q: How might the Inflation Reduction Act affect drug pricing in the coming years? A: The Inflation Reduction Act introduces Medicare drug price negotiations for certain high-cost drugs, which could lead to lower prices for these medications. It also includes provisions to cap out-of-pocket costs for Medicare beneficiaries, which may indirectly influence overall drug pricing strategies.
-
Q: What role do pharmacy benefit managers (PBMs) play in drug pricing? A: PBMs negotiate drug prices with manufacturers on behalf of insurers and employers. They create formularies, manage rebates, and can significantly influence which drugs are covered and at what cost to patients.
-
Q: How can patients find the most up-to-date pricing information for a specific drug? A: Patients can check with their insurance provider, use online price comparison tools, or consult with their pharmacist for the most current pricing information. It's important to note that prices can vary significantly between pharmacies and based on insurance coverage.
Sources cited: [1] https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory [2] https://www.drugpatentwatch.com/p/drug-price/ndc/69452-0146 [3] https://www.drugpatentwatch.com/p/drug-price/ndc/69315-0275 [4] https://fda.report/NDC/69452-233 [5] https://aspe.hhs.gov/sites/default/files/documents/0cdd88059165eef3bed1fc587a0fd68a/aspe-drug-price-tracking-brief.pdf [8] https://aspe.hhs.gov/sites/default/files/documents/3e8abec86039ac0ed674a8c5fac492e3/price-change-over-time-brief.pdf
More… ↓
